Sensitization of the Escherichia coli cyclic AMP receptor protein to trypsin cleavage by polydeoxyribonucleotides and polyribonucleotides.
In the absence of cAMP the cyclic AMP receptor protein (CRP) is relatively resistant to trypsin whereas the cAMP X CRP complex is attacked yielding N-terminal core fragments of 14,300 and 18,500 Da which still bind cAMP. The DNA X CRP complex formed at low ionic strength in the absence of cAMP is cleaved by trypsin with the formation of 9,700- and 6,000-Da fragments and the concomitant loss of cAMP binding activity. DNA X CRP remains as resistant to attack by subtilisin, clostripain, and the Staphylococcus aureus V8 protease as unliganded CRP but is slowly digested by chymotrypsin. All of the double-stranded polydeoxyribonucleotides and several of the single-stranded polydeoxyribonucleotides and polyribonucleotides tested render CRP sensitive to cleavage by trypsin. CRP is less rapidly cleaved by trypsin in the presence of d(A)n, d(I)n, and r(C)n indicative of a weaker affinity of CRP for these polynucleotides. The 9,700-Da fragment is N-terminal in CRP and probably terminates at Lys-89. The loss of cAMP binding activity following trypsin cleavage of DNA X CRP indicates that regions beyond this residue are important in the function of the cAMP-binding domain of CRP. The 6,000-Da fragment extends from Val-131 to Arg-185 or Lys-188 and contains part of the F helix involved in DNA binding by CRP.
D000595:Amino Acid Sequence; D000242:Cyclic AMP / Q000378:metabolism; D004926:Escherichia coli / Q000032:analysis*; D009994:Osmolar Concentration; D010446:Peptide Fragments / Q000032:analysis; D011089:Polydeoxyribonucleotides / Q000494:pharmacology*; D011131:Polyribonucleotides / Q000494:pharmacology*; D011953:Receptors, Cyclic AMP / Q000378:metabolism*; D013997:Time Factors; D014357:Trypsin / Q000378:metabolism*
D010446:Peptide Fragments; D011089:Polydeoxyribonucleotides; D011131:Polyribonucleotides; D011953:Receptors, Cyclic AMP; D000242:Cyclic AMP; D014357:Trypsin